The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(2-Methoxyethyl)-3-methyl-7-(5-methyl-2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one ID: ALA4086507
PubChem CID: 137641993
Max Phase: Preclinical
Molecular Formula: C20H25N7O2
Molecular Weight: 395.47
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COCCN1C(=O)c2cc(-c3nc(Nc4ccnn4C)ncc3C)cn2C[C@H]1C
Standard InChI: InChI=1S/C20H25N7O2/c1-13-10-21-20(23-17-5-6-22-25(17)3)24-18(13)15-9-16-19(28)27(7-8-29-4)14(2)11-26(16)12-15/h5-6,9-10,12,14H,7-8,11H2,1-4H3,(H,21,23,24)/t14-/m1/s1
Standard InChI Key: MLMCYOUMLZXVEE-CQSZACIVSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
14.4032 -8.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1190 -8.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4032 -9.3250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8308 -8.5001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8308 -9.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1190 -9.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6186 -8.2429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1339 -8.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6186 -9.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1190 -7.2626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0714 -9.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8964 -9.6242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3089 -8.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8964 -8.1967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0714 -8.1967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6589 -8.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6589 -10.3401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3491 -9.6747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5645 -9.9276 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5645 -10.7526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3491 -11.0055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8339 -10.3401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6021 -8.8900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3089 -7.4808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5466 -9.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5466 -8.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2583 -8.5001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2583 -9.3250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9741 -9.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 1 0
4 5 1 0
5 6 1 0
3 6 1 0
7 8 1 0
8 9 2 0
3 9 1 0
1 7 2 0
2 10 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
18 22 1 0
18 23 1 0
17 22 1 0
11 17 1 0
14 24 1 0
8 13 1 0
5 25 1 6
26 27 1 0
28 29 1 0
27 28 1 0
4 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.47Molecular Weight (Monoisotopic): 395.2070AlogP: 2.22#Rotatable Bonds: 6Polar Surface Area: 90.10Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.78CX Basic pKa: 3.05CX LogP: 1.95CX LogD: 1.95Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -1.42
References 1. Ward RA, Bethel P, Cook C, Davies E, Debreczeni JE, Fairley G, Feron L, Flemington V, Graham MA, Greenwood R, Griffin N, Hanson L, Hopcroft P, Howard TD, Hudson J, James M, Jones CD, Jones CR, Lamont S, Lewis R, Lindsay N, Roberts K, Simpson I, St-Gallay S, Swallow S, Tang J, Tonge M, Wang Z, Zhai B.. (2017) Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start Point., 60 (8): [PMID:28376306 ] [10.1021/acs.jmedchem.7b00267 ]